• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Social Work Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Med Fact Book App
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » Capacity Evaluation
Clinical Update

Capacity Evaluation

October 31, 2023
Rehan Aziz, MD
From The Carlat Geriatric Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

Rehan Aziz, MD. Associate program director, geriatric psychiatry fellowship program, Jersey Shore University Medical Center, Neptune, NJ; associate professor of psychiatry and neurology, Hackensack Meridian School of Medicine, Nutley, NJ.

Dr. Aziz has no financial relationships with companies related to this material. 

You are asked by one of the internists in your hospital to see Ms. Jones, an 86-year-old woman with dementia and severe depression, who is hospitalized with a urinary tract infection. Over the past two days, Ms. Jones has refused to take her antibiotic despite encouragement from her team. Does she have the capacity to refuse antibiotic treatment?

We are often consulted to determine decision-making capacity (DMC) in patients with dementia or other cognitive impairments. This is usually in the setting of a patient who has been admitted for a medical issue and who must make significant decisions about their treatment. How should you go about determining DMC in these cases? 

Criteria for DMC

DMC is a fundamental aspect of autonomy. It enables individuals to make their own decisions and exercise control over their lives. Adults are assumed to have DMC, but cognitive disorders like dementia and delirium can reduce this ability to varying degrees and with varying prognoses. Determining DMC is a complex and nuanced process. 

When it comes to informed consent, managing finances, living independently, making a will, and driving, patients with dementia can’t be assumed to lack capacity. Instead, DMC must be determined on a case-by-case basis. The process of determining capacity typically involves assessing four key components: communication, understanding, appreciation, and reasoning (Appelbaum PS, N Engl J Med 2007;357(18):1834–1840). See “Components of Capacity Evaluations” table. 

A patient’s capacity for a specific decision will depend on their ability to meet all these criteria. However, the level of capacity needed for different decisions can vary. For example, a decision about daily care may require less capacity than a decision about complex medical treatment or major surgery.

Is it capacity or competence?

I often see these terms confused with each other. However, capacity and competence are related but distinct concepts.

Capacity

Capacity refers to a patient’s ability to make a specific decision at a specific time. It’s based on the patient’s cognitive function and the four principles described above. It is not a fixed state and can fluctuate over time, especially in response to medication side effects, delirium, or cognitive decline. 

Competence

Competence is a legal determination made by a judge or a court of law, not by clinicians. It’s a finding of a person’s legal ability to make decisions and manage their own affairs. Competence is usually used in the context of guardianship or conservatorship. Criteria to determine competence can vary by country and jurisdiction. In some cases, a person may be deemed competent to make some decisions but not others.

Capacity in people with dementia

Persons with dementia who have preserved awareness of their diagnosis, symptoms, and prognosis are likely to retain capacity to make decisions about their care (Karlawish J, Neurosignals 2008;16(1):91–98). Other patients with dementia may still be able to make decisions related to their daily care, but may not have the capacity to make complex treatment choices, such as creating a living will or making end-of-life decisions. 

Here are the steps I take to evaluate capacity in a patient with dementia:

Assess cognitive function

This first step can be done through a variety of tests, such as the Mini-Mental State Exam (MMSE) or the Montreal Cognitive Assessment (MoCA). These tests provide a general assessment of the patient’s cognitive abilities but are not specific for determining DMC. However, in Alzheimer’s disease, an MMSE score below 19 is associated with incapacity, and patients scoring above 23 are very likely to have DMC (Karlawish JHT et al, s2005;64(9):1514–1519). Thus, a patient with an MMSE score of 19–23 may benefit the most from a detailed evaluation of their capacity to make decisions. Keep in mind that cognitive testing may not be as useful among populations without access to higher education, especially racially or economically minoritized populations, as well as among non-native English speakers.

Respect the patient’s autonomy

It is essential to involve the patient in the decision-making process as much as possible. To improve your chances of getting the patient involved, use clear and simple explanations to help them understand the options available and what the consequences of their choices might be. For example, you might say to Ms. Jones: “I see you are not taking the antibiotic. These pills helped you the last time you had an infection. If you stop them now, your infection might continue to make you feel lousy.”

Assess the specific decision using the four principles of capacity

You might say: “Ms. Jones, please tell me why you are in the hospital. Why did you stop taking the antibiotic? What do you think will happen by not taking these pills? What are other treatments for your infection? What are the benefits of the pills? What are the risks of not taking the pills today?”

Involve the patient and their family

The patient’s family members can provide valuable insight into the patient’s baseline decision-making abilities, preferences, and values. Remember to ask the patient for permission before discussing their medical information with others. When your patient is not at their psychiatric baseline, use your professional judgment in determining whether communication is in the best interest of the patient.

For challenging cases, engage a multidisciplinary team 

A multidisciplinary team can include a geriatrician, a psychiatrist, a social worker, and/or legal experts such as a bioethics committee to help assess the patient’s capacity and to make ­recommendations.

Reevaluate regularly

As the patient’s condition changes over time, it’s important to reevaluate their capacity often to ensure that they still have the ability to make decisions. Reevaluation frequency varies based on the underlying cause and expected time course of mental status changes. For example, you might reevaluate daily following an overdose, or every few months in dementia. 

Tools for determining capacityCGPR OctNovDec2023 Table_CapacityEvals_p7.png

Clinicians can use cognitive screens like the MMSE or MoCA as decision aids, but these screens are not stand-alone diagnostic tools for DMC.

There are several tools that can help assess capacity, but none are universally accepted, and most are lengthy and primarily used in research. One worth looking at is the Aid to Capacity Evaluation (ACE), which aims to help clinicians systematically evaluate capacity when a patient is facing a medical decision. The ACE can be found at the University of Toronto Joint Centre for Bioethics’ webpage (www.tinyurl.com/4bznbpp5) and takes 10–15 minutes to administer.

Ms. Jones scores 15/30 on the MoCA, which is consistent with your concerns about her limited decision-making abilities related to her dementia. You ask her why she does not wish to take her antibiotic, and she expresses concern that her doctors never evaluated her for infection and are giving her the incorrect treatment. You review what happened the last time she stopped her antibiotic (she developed pain when urinating and was medically hospitalized), but Ms. Jones does not think her medications are related to that earlier episode. Despite encouragement from her family, she will not take her antibiotic. 

Surrogate decision-makers

If a patient is found to lack DMC after evaluating the four key components of capacity, the next stage is to assign a surrogate decision-maker. A health care proxy (HCP) is a person designated by the patient to make medical decisions on their behalf in the event they cannot make their own decisions. The HCP is invoked when the patient is deemed to lack capacity to make a medical decision. If a patient does not have a designated HCP, family members or loved ones can engage in the legal process of obtaining guardianship to make medical decisions for the patient, although this is often a time-consuming process. In these situations, it’s critical to ensure that the patient is protected from abuse or exploitation. 

Although Ms. Jones can communicate her choice, she demonstrates an inability to appreciate the consequences of not taking her medication, and she is unable to provide a logical rationale for refusing it. You determine she does not have capacity to refuse her antibiotic at this time and ask her HCP whether she is in agreement to continue the patient’s antibiotic.

CARLAT VERDICT 

 Capacity is a clinical assessment that can be supported by standardized measures. Determining capacity requires a careful and individualized assessment of a patient’s understanding of relevant information, communication of a choice, appreciation of the situation, and reasoning abilities. It’s important to strike a balance between respecting a patient’s autonomy and acting on their behalf.                                                        
Geriatric Psychiatry Clinical Update
KEYWORDS aid-to-capacity-evaluation-ace capacity Delirium Dementia mmse surrogate decision maker
    Rehan Aziz, MD

    Breaking the Silence: Addressing the Hidden Crisis of Elder Abuse

    More from this author
    www.thecarlatreport.com
    Issue Date: November 3, 2023
    SUBSCRIBE NOW
    Table Of Contents
    Learning Objectives, Caring for Patients at End of Life, CGPR, October/November/December 2023
    Safe Driving for Older Adults
    End-of-Life Discussions With Patients With Advanced Dementia
    Capacity Evaluation
    Spirituality in Practice
    Optimal Levels of Care for Older Adults
    Brexpiprazole
    CME Post-Test, Caring for Patients at End of Life, CGPR, October/November/December 2023
    DOWNLOAD NOW
    Featured Book
    • MFB7e_Print_App_Access.png

      Medication Fact Book for Psychiatric Practice, Seventh Edition (2024) - Regular Bound Book

      The updated 2024 reference guide covering the most commonly prescribed medications in psychiatry.
      READ MORE
    Featured Video
    • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
      General Psychiatry

      KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

      Read More
    Featured Podcast
    • shutterstock_2603816031.jpg
      General Psychiatry

      A Scam for Every Woman, Child, and Man: Part 2

      1 in 3 Americans were victims of online scams in the past year. Even when you know your patient is being scammed, it is hard to pull them out. We speak with Cathy Wilson about...
      Listen now
    Recommended
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png

    About

    • About Us
    • CME Center
    • FAQ
    • Contact Us

    Shop Online

    • Newsletters
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN Self-Assessment Courses

    Newsletters

    • The Carlat Psychiatry Report
    • The Carlat Child Psychiatry Report
    • The Carlat Addiction Treatment Report
    • The Carlat Hospital Psychiatry Report
    • The Carlat Geriatric Psychiatry Report
    • The Carlat Psychotherapy Report

    Contact

    carlat@thecarlatreport.com

    866-348-9279

    PO Box 626, Newburyport MA 01950

    Follow Us

    Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

    © 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.